Neutrophil hyperchemotaxis in Behçet's disease: A possible role for monocytes orchestrating bacterial-induced innate immune responses

Clinical Rheumatology

Volumn 28, Issue 12, 2009, Pages 1403-1410

  Neves, Fabricio Souza ^a   Carrasco, Solange ^a   Goldenstein Schainberg, Cláudia ^a   Gonçalves, Célio Roberto ^a   De Mello, Suzana Beatriz Veríssimo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Beh et's disease; Chemotaxis; Monocytes; Neutrophils; Toll like receptors

Indexed keywords

CD14 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 6; LIPOTEICHOIC ACID; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ADULT; ARTICLE; BACTERIAL IMMUNITY; BEHCET DISEASE; CELL MEMBRANE; CELL STIMULATION; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; HUMAN CELL; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; STAPHYLOCOCCUS AUREUS;

ADOLESCENT; ADULT; ANTIGENS, CD; BEHCET SYNDROME; BIOLOGICAL MARKERS; CELLS, CULTURED; CHEMOTACTIC FACTORS; CHEMOTAXIS, LEUKOCYTE; FEMALE; HUMANS; IMMUNITY, INNATE; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; MONOCYTES; NEUTROPHIL ACTIVATION; NEUTROPHILS; SEVERITY OF ILLNESS INDEX; TEICHOIC ACIDS; TOLL-LIKE RECEPTORS; YOUNG ADULT;

EID: 70450248419     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-009-1261-5     Document Type: Article

References (38)

1. S Yurdakul V Hamuryudan H Yazici 2004 Behçet syndrome Curr Opin Rheumatol 16 38 42 10.1097/00002281-200401000-00008 14673387 (Pubitemid 38041397)
2. H Direskeneli 2006 Autoimmunity vs autoinflammation in Behçet's disease: do we oversimplify a complex disorder? Rheumatology 45 1461 1465 10.1093/rheumatology/kel329 1:STN:280:DC%2BD28notlGjug%3D%3D 16998234 (Pubitemid 44817050)
3. N Matsumara Y Mizushima 1975 Leucocyte movement and colchicine treatment in Behçet's disease Lancet 2 813 10.1016/S0140-6736(75)80031-6
4. A Carletto ML Pacor D Biasi, et al. 1997 Changes of neutrophil migration without modification of in vitro metabolism and adhesion in Behçet's disease J Rheumatol 24 1332 1336 1:STN:280:DyaK2szntFylug%3D%3D 9228133
5. B Tüzün Y Tüzün S Yurdakul V Hamuryudan H Yazici Y Ozyazgan 1999 Neutrophil chemotaxis in Behçet's syndrome Ann Rheum Dis 58 658 10.1136/ard.58.10.658 10577375
6. The Behçet's Disease Research Committee of Japan 1989 Skin hypersensitivity to streptococcal antigens and the induction of systemic symptoms by the antigens in Behçet's disease-a multicenter study J Rheumatol 16 506 511
7. T Lehner 1999 Immunopathogenesis of Behçet's disease Ann Med Interne (Paris) 150 483 487 1:CAS:528:DC%2BD3cXht1emsw%3D%3D
8. H Direskeneli E Eksioglu-Demiralp S Yavuz, et al. 2000 T cell responses to 60/65 kDa heat shock protein derived peptides in Turkish patients with Behçet's disease J Rheumatol 27 708 713 1:CAS:528:DC%2BD3cXit1Smtrc%3D 10743813
9. M Calguneri S Kiraz I Ertenli M Benekli Y Karaarslan I Celik 1996 The effect of prophylactic penicillin treatment on the course of arthritis episodes in patients with Behçet's disease Arthritis Rheum 39 2062 2065 10.1002/art.1780391216 1:CAS:528:DyaK2sXjt12luw%3D%3D 8961912 (Pubitemid 27009075)
10. Y Niwa Y Mizushima 1990 Neutrophil-potentiating factors released from stimulated lymphocytes; special reference to the increased in neutrophil-potentiating factors from streptococcus-stimulated lymphocytes of patients with Behçet's disease Clin Exp Immunol 79 353 360 1:CAS:528:DyaK3cXhvFKntrs%3D 2180598
11. R Medzhitov P Hurlburt-Preston CA Janeway Jr 1997 A human homologue of the Drosophila Toll protein signs activation of adaptive immunity Nature 388 394 397 10.1038/41131 1:CAS:528:DyaK2sXkvVChurc%3D 9237759 (Pubitemid 27334820)
12. MF Roelofs S Abdollahi-Roodsaz LAB Joosten WB van den Berg TRDJ Radstake 2008 The orchestra of Toll-like receptor and their potential role in frequently occurring rheumatic conditions Arthritis Rheum 58 338 348 10.1002/art.23217 1:CAS:528:DC%2BD1cXivFahtrw%3D 18240239 (Pubitemid 351294868)
13. S Lotz E Aga I Wilde, et al. 2004 Highly purified lipoteichoic acid activates neutrophil granulocytes and delays their spontaneous apoptosis via CD14 and TLR2 J Leuk Biol 75 467 477 10.1189/jlb.0803360 1:CAS:528: DC%2BD2cXis1ehs7o%3D (Pubitemid 38316378)
14. NWJ Schröder S Morath C Alexander, et al. 2003 Lipoteichoic Acid (LTA) of streptococcus pneumoniae and staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lypopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved J Biol Chem 278 15587 15594 10.1074/jbc.M212829200 12594207 (Pubitemid 36799667)
15. EA Kurt-Jones L Mandell C Whitney, et al. 2002 Role of Toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR-2 mediated interleukin 8 responses in neutrophils Blood 100 1860 1868 1:CAS:528:DC%2BD38Xmslyhtbw%3D 12176910
16. JE Do SY Kwon S Park ES Lee 2008 Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behçet's disease Rheumatology 47 840 848 10.1093/rheumatology/ken109 1:CAS:528: DC%2BD1cXmtlentLw%3D 18411217 (Pubitemid 351796370)
17. Y Kirino M Takeno R Watanabe, et al. 2008 Association of reduced heme oxygenase-1 with excessive Toll-like receptor 4 expression in peripheral blood mononuclear cells in Behçet's disease Arthritis Res Ther 10 R16 10.1186/ar2367 18234118 (Pubitemid 351280041)
18. K Nara MS Kurokawa S Chiba, et al. 2008 Involvement of innate immunity in the pathogenesis of intestinal Behçet's disease Clin Exp Immunol 152 245 251 1:CAS:528:DC%2BD1cXmsV2nt7s%3D 18336589
19. S Yavuz Y Elbir A Tulunay E Eksioglu-Demiralp H Direskeneli 2008 Differential expression of toll-like receptor 6 on granulocytes and monocytes implicates the role of microorganisms in Behçet's disease etiopathogenesis Rheumatol Int 28 401 406 10.1007/s00296-007-0470-y 1:CAS:528:DC%2BD1cXhvFOrs70%3D 17934735 (Pubitemid 351629487)
20. I Sabroe LR Prince EC Jones, et al. 2003 Selective roles for Toll-like receptor (TLR)2 and TLR4 in the regulation of neutrophil activation and life span J Immunol 170 5268 5275 1:CAS:528:DC%2BD3sXjsVGqtrk%3D 12734376
21. I Sabroe EC Jones MKB Whyte SK Dower 2005 Regulation of human neutrophil chemokine receptor expression and function by activation of Toll-like receptors 2 and 4 Immunology 115 90 98 10.1111/j.1365-2567.2005.02133.x 1:CAS:528:DC%2BD2MXjvFaqt70%3D 15819701 (Pubitemid 40593295)
22. K Aomatsu T Kato H Fujita, et al. 2007 Toll-like receptor agonists stimulate human neutrophil migration via activation of mitogen-activated protein kinases Immunology 123 171 180 17662043
23. S Bas BR Gauthier U Spenato S Stingelin C Gabay 2004 CD14 is an acute-phase protein J Immunol 172 4470 4479 1:CAS:528:DC%2BD2cXitlOqtLw%3D 15034063
24. International Study Group for Behçet's Disease 1991 Criteria for diagnosis of Behçet's Disease Lancet 335 1078 1080
25. FS Neves JCB Moraes SC Kowalski C Goldenstein-Schainberg LV Lage CR Gonçalves 2007 Cross-cultural adaptation of the Behçet's Disease Current Activity Form (BDCAF) to Brazilian Portuguese language Clin Rheumatol 26 1263 1267 10.1007/s10067-006-0484-y 1:STN:280:DC%2BD2sznvVyhtg%3D%3D 17180637 (Pubitemid 47034180)
26. BB Bhakta P Brennan TE James MA Chamberlain BA Noble AJ Silman 1999 Behçet's disease: evaluation of a new instrument to measure clinical activity Rheumatology 38 728 733 10.1093/rheumatology/38.8.728 1:STN:280:DyaK1MvivFGhug%3D%3D 10501420 (Pubitemid 29507389)
27. G Mumcu N Inanc S Yavuz H Direskeneli 2007 The role of infectious agents in the pathogenesis, clinical manifestations and treatment strategies in Behçet's disease Clin Exp Rheumatol 25 4 Suppl 45 S27 S33 1:STN:280:DC%2BD2snntVCgug%3D%3D 17949548
28. R Tunc E Keyman M Melikoglu, et al. 2002 Target organ associations in Turkish patients with Behçet's disease: a cross sectional study by exploratory factor analysis J Rheumatol 29 2393 2396 12415598
29. E Diri C Mat V Hamuryudan S Yurdakul N Hizli H Yazici 2001 Papulopustular skin lesions are seen more frequently in patients with Behçet's syndrome who have arthritis: a controlled and masked study Ann Rheum Dis 60 1074 1076 10.1136/ard.60.11.1074 1:STN:280:DC%2BD3MrlsFCntw%3D%3D 11602484 (Pubitemid 32989185)
30. JD Sobel S Haim N Obedeanu T Meshulam D Merzbach 1977 Polymorphonuclear leukocyte function in Behçet's disease J Clin Pathol 30 250 253 10.1136/jcp.30.3.250 1:STN:280:DyaE2s7ktFaktA%3D%3D 845272
31. A Kurihara F Ojima S Tsurufuji 1984 Analysis of the effect of an anti-inflammatory steroid, dexamethasone, on neutrophil chemotaxis in the Boyden chamber with a modified 51Cr-labeling method J Pharmacobiodyn 7 747 754 1:CAS:528:DyaL2MXhslyrsQ%3D%3D 6520696
32. JL Mege N Dilsen V Sanguedolce, et al. 1993 Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increase neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranen fever and healthy subjects J Rheumatol 20 1544 1549 1:STN:280:DyaK2c3hslWhtw%3D%3D 8164212
33. M Cuchacovich G Merino JH Yamamoto, et al. 2005 Behçet's disease patients present high levels of deglycosylated anti-lipoteichoic acid IgG and high IL-8 production after lipoteichoic acid stimulation Clin Exp Rheumatol 23 4 Suppl.38 S27 S34 1:STN:280:DC%2BD2MrpsV2msA%3D%3D 16273761
34. S Sahin R Lawrence H Direskeneli V Hamuryudan H Yazici T Akoglu 1996 Monocyte activity in Behçet's disease Br J Rheumatol 35 424 429 10.1093/rheumatology/35.5.424 1:STN:280:DyaK283jsFWjsg%3D%3D 8646431
35. CR Maliszewski 1991 CD14 and immune response to lipopolysaccharide Science 252 1321 1322 10.1126/science.1718034 1:CAS:528:DyaK3MXks12ls70%3D 1718034
36. J Pugin CC Schürer-Maly D Leturcq A Moriarty RJ Ulevitch PS Tobias 1993 Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14 Proc Natl Acad Sci USA 90 2744 2748 10.1073/pnas.90.7.2744 1:CAS:528:DyaK3sXitlahsbk%3D 7681988
37. A Troelstra BN Giepmans KP Van Kessel HS Lichenstein J Verhoef JA Van Strijp 1997 Dual effects of soluble CD14 on LPS priming of neutrophils J Leukoc Biol 61 173 178 1:CAS:528:DyaK2sXhtVOrtbk%3D 9021923
38. AM Soler-Rodriguez H Zhang HS Lichenstein, et al. 2000 Neutrophil activation by bacterial lipoprotein versus lipopolysaccharide: differential requirements for serum and CD14 J Immunol 164 2674 2683 1:CAS:528: DC%2BD3cXhsVKhtLo%3D 10679108